This inventor holds 2 USPTO granted patents. Top assignee: Academia Sinica. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Yi-Ming Chiang: Innovator in Immunomodulatory Treatments
Introduction
Yi-Ming Chiang is a notable inventor based in Taipei County, Taiwan. He has made significant contributions to the field of immunology, particularly in the treatment of Th1-mediated disorders. With a total of 2 patents, his work is recognized for its potential impact on various autoimmune conditions.
Latest Patents
Yi-Ming Chiang's latest patents include a method for treating Th1-mediated disorders. This method involves administering an effective amount of a compound of a specific formula to subjects in need of treatment. The disorders targeted by this invention include non-obese diabetes, Crohn's colitis, autoimmune hemolytic anemia, rheumatoid arthritis, autoimmune encephalitis, multiple sclerosis, and autoimmune myocarditis. Additionally, he has developed immunomodulatory compositions that are useful in identifying plant compositions with immunomodulatory activity. These compositions are particularly beneficial for increasing immune responses, such as IFN-γ or IL-2 transcription.
Career Highlights
Yi-Ming Chiang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to focus on innovative research in immunology and related fields. His contributions have been instrumental in advancing the understanding and treatment of autoimmune disorders.
Collaborations
Some of his notable coworkers include Wen-Chin Yang and Shu-Lin Chang. Their collaborative efforts have further enhanced the research output and innovation in their respective fields.
Conclusion
Yi-Ming Chiang's work exemplifies the importance of innovation in the treatment of complex medical conditions. His patents and research contributions continue to pave the way for advancements in immunology and therapeutic strategies.